Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 213 of 1,261
  1. US 11564981

    Vaccine for prevention of necrotic enteritis in poultry

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  2. US 11566007

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  3. US 11566149

    Coatings containing polymer modified enzyme for stable self-cleaning of organic stains

    Regents of the University of Minnesota · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  4. US 11564884

    Cationic block polymer micelles for delivery of biological agents

    Regents of the University of Minnesota · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  5. US 11564979

    Stabilized liquid and lyophilized ADAMTS13 formulations

    Takeda Pharmaceutical Company Limited · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  6. US 11564937

    Nucleoporins as drug targets for anti-proliferative therapeutics

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  7. US 11565000

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  8. US 11564930

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  9. US 11564926

    Methods of synthesizing thyroid hormone analogs and polymorphs thereof

    Madrigal Pharmaceuticals, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  10. US 11565001

    Adeno-associated virus virions with variant capsid and methods of use thereof

    The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  11. US 11564888

    Extended release compositions comprising trihexyphenidyl

    Amneal Complex Products Research LLC · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  12. US 11566015

    Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  13. US 11566078

    PDL1-binding proteins

    Inhibrx, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  14. US 11566016

    MAP kinase modulators and uses thereof

    Northwestern University · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  15. US 11564935

    Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

    Compass Pathfinder Limited · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  16. US 11564997

    Materials and methods for treatment of friedreich ataxia and other related disorders

    CRISPR THERAPEUTICS AG · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  17. US 11566255

    Expression of PEDV sequences in plants and plant produced vaccine for same

    Mazen Animal Health, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  18. US 11566242

    Methods and compositions for reprogramming cells

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  19. US 11564896

    Methods of treatment

    First Wave Bio, Inc. · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  20. US 11566002

    Substituted tetrahydrocyclopenta[C]pyrroles, substituted dihydropyrrolizines, analogues thereof, and methods using same

    ARBUTUS BIOPHARMA CORPORATION · Granted Jan 31, 2023 · Expires Jan 26, 2043

    granted
  21. US 11560366

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  22. US 11559583

    Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for cancer

    Five Prime Therapeutics, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  23. US 11560363

    Synthesis of esuberaprost prodrugs

    United Therapeutics Corporation · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  24. US 11559585

    Conjugates of active pharmaceutical ingredients

    The Regents of the University of California · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.